Vaccines for visceral leishmaniasis: A review
K Jain, NK Jain - Journal of immunological methods, 2015 - Elsevier
Visceral leishmaniasis, which is also known as Kala-Azar, is one of the most severely
neglected tropical diseases recognized by the World Health Organization (WHO). The threat …
neglected tropical diseases recognized by the World Health Organization (WHO). The threat …
Case study for a vaccine against leishmaniasis
Leishmaniasis in many ways offers a unique vaccine case study. Two reasons for this are
that leishmaniasis is a disease complex caused by several different species of parasite that …
that leishmaniasis is a disease complex caused by several different species of parasite that …
Mechanisms of immune evasion in leishmaniasis
G Gupta, S Oghumu, AR Satoskar - Advances in applied microbiology, 2013 - Elsevier
Diseases caused by Leishmania present a worldwide problem, and current therapeutic
approaches are unable to achieve a sterile cure. Leishmania is able to persist in host cells …
approaches are unable to achieve a sterile cure. Leishmania is able to persist in host cells …
Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasite
Visceral Leishmaniasis (VL) is an insect-borne neglected disease caused by the protozoan
parasite Leishmania donovani. In the absence of a commercial vaccine against VL …
parasite Leishmania donovani. In the absence of a commercial vaccine against VL …
Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules
S Asthana, AK Jaiswal, PK Gupta… - Antimicrobial agents …, 2013 - Am Soc Microbiol
The accessible treatment options for life-threatening neglected visceral leishmaniasis (VL)
disease have problems with efficacy, stability, adverse effects, and cost, making treatment a …
disease have problems with efficacy, stability, adverse effects, and cost, making treatment a …
[HTML][HTML] An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania …
Background Visceral leishmaniasis (VL) caused by dimorphic Leishmania species is a
parasitic disease with high socioeconomic burden in endemic areas worldwide. Sustaining …
parasitic disease with high socioeconomic burden in endemic areas worldwide. Sustaining …
[HTML][HTML] Visceral leishmaniasis: advancements in vaccine development via classical and molecular approaches
Visceral leishmaniasis (VL) or kala-azar, a vector-borne protozoan disease, shows
endemicity in larger areas of the tropical, subtropical and the Mediterranean countries. WHO …
endemicity in larger areas of the tropical, subtropical and the Mediterranean countries. WHO …
[HTML][HTML] Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis
MC Duarte, DP Lage, VT Martins… - Revista da Sociedade …, 2016 - SciELO Brasil
Visceral leishmaniasis (VL) is one of the most important tropical diseases worldwide.
Although chemotherapy has been widely used to treat this disease, problems related to the …
Although chemotherapy has been widely used to treat this disease, problems related to the …
Hamster, a close model for visceral leishmaniasis: Opportunities and challenges
Aim Visceral leishmaniasis (VL) caused by parasites belonging to genus Leishmania (L.) is
classified as a category I disease by the TDR/WHO. The understanding of the pathogenesis …
classified as a category I disease by the TDR/WHO. The understanding of the pathogenesis …
A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand flies
H Aslan, R Dey, C Meneses… - The Journal of …, 2013 - academic.oup.com
Background. Visceral leishmaniasis (VL) is transmitted by sand flies. Protection of needle-
challenged vaccinated mice was abrogated in vector-initiated cutaneous leishmaniasis …
challenged vaccinated mice was abrogated in vector-initiated cutaneous leishmaniasis …